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Abstract
Background: Moyamoya disease (MMD) is a cerebrovascular disease characterized by progressive stenosis or occlusion of
the terminal portion of internal carotid arteries and the formation of a vascular network at the base of the brain. The
pathogenesis of MMD is still unclear.
Methodology/Principal Findings: We retrospectively analyzed clinical data for 65 consecutive patients with MMD in our
institutions and evaluated the histopathological and immunohistochemical findings of intracranial vessels from 3 patients.
The onset age distribution was found to have 1 peak at 40–49 year-old age group, no significant difference was observed in
the female-to-male ratio (F/M=1.2). Intracranial hemorrhage was the predominant disease type (75%). Positive family
history was observed in 4.6% of patients. Histopathological findings were a narrowed lumen due to intimal fibrous
thickening without significant inflammatory cell infiltration, and the internal elastic lamina was markedly tortuous and
stratified. All 3 autopsy cases showed vacuolar degeneration in the cerebrovascular smooth muscle cells. Immunohisto-
chemical study showed the migration of smooth muscle cells in the thickened intima, and aberrant expression of IgG and
S100A4 protein in vascular smooth muscle cells. The Complement C3 immunoreactivity was negative.
Conclusion/Significance: This study indicated that aberrant expression of IgG and S100A4 protein in intracranial vascular
wall of MMD patients, which suggested that immune-related factors may be involved in the functional and morphological
changes of smooth muscle cells, and finally caused the thickened intima. A possible mechanism is that deposits of IgG in the
damaged internal elastic lamina may underlie the disruption of internal elastic lamina, which facilitated S100A4 positive
SMCs migrated into intima through broken portions of the internal elastic lamina, resulting in lumen stenosis or occlusion,
leading to compensatory small vessels proliferation.
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Introduction
Moyamoya disease (MMD), also known as spontaneous
occlusion of the circle of Willis, is a cerebrovascular disease
characterized by progressive stenosis or occlusion of the terminal
portion of internal carotid arteries [1]. The abnormal vascular
networks (Moyamoya vessels) at the base of the brain act as
collateral channels because of ischemic changes occurring in the
brain tissue. These fragile vascular networks resemble a ‘‘puff of
smoke’’ (Japanese: Moyamoya) on angiography imaging and
hence the disease name [2].
This clinical disease was first reported in Japan as hypogenesis
of the bilateral internal carotid arteries [3]. MMD occurs
predominantly but not exclusively in Japan. The incidence is high
in East Asian countries [4] such as Japan and Korea. A 2003
survey found the total number of patients treated in Japan
estimated at 7700 [5], an almost 100% increase during the decade
(3,900 in 1994). The female-to-male ratio was 1.8, and 12.1% of
patients had a family history of the disease. The crude prevalence
was calculated as 6.03 per 100,000 people, and in 2003, the
annual rate of newly diagnosed cases was 0.54 per 100,000 people.
However, the epidemiological features of MMD in mainland
China have not been reported officially.
Patients with MMD show 3 disease types: cerebral ischemia
(transient ischemic attack and infarction), hemorrhage (intracere-
bral, intraventricular and subarachnoid), and no symptoms. MMD
occurs in both children and adults, but the clinical features differ.
Most pediatric patients experience transient ischemic attack (TIA)
or cerebral infarction, whereas, about half of adult patients
experience intracranial hemorrhage [6].
The pathogenesis of MMD is still unclear, although extensive
studies have been carried out all over the world. Pathology
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outer diameters of the affected internal carotid artery terminations
markedly diminished. Microscopically, the arteries of the circle of
Willis show narrowed lumen, fibrocellular intimal thickening,
marked tortuousness of internal elastic lamina and attenuation of
media, with thickened intima composed of smooth muscle cells.
With the improvement of diagnostic techniques, the number of
reported cases of MMD have increased, once symptomatic,
insufficient cerebral blood flow or rupture of the fragile collaterals
may cause stroke or hemorrhage, thus resulting in severe
neurological dysfunction or death.
Here, we present a retrospective analysis of cases of MMD in
our institutions, pathology and immunohistochemical results of 3
autopsy cases, to describe the demographic profile, clinical
features, and histopathological changes of intracranial vessels in
patients with MMD.
Materials and Methods
1. Cases
We collected records for 38 patients with MMD treated at the
First Affiliated Hospital, and 24 treated at the Second Affiliated
Hospital, Shantou University Medical College, from April 2005 to
September 2011. In addition, we obtained material for 3 autopsy
cases of MMD from the Judicial Critical Center, Shantou
University Medical College. All patients had undergone CT scan
of the head and cerebral angiography to confirm the diagnosis.
The diagnosis of MMD was based on the guidelines established by
the Research Committee on Moyamoya Disease (Spontaneous
Occlusion of the Circle of Willis) of the Ministry of Health and
Welfare of Japan [7]. All participants involved in our study were
given written informed consents. Our research has been approved
by Ethical Committee of Shantou University Medical College. To
compare the clinical features of MMD in different districts, we also
obtain articles about MMD written in English (published between
1997 and 2012) through Medline via PubMed (4089 cases,
including 65 cases in our institutions).
2. Autopsy specimens
At autopsy, the specimens of brain vessels were obtained from 3
adult patients with MMD and fixed in 10% formalin solution.
Sections with the circle of Willis and its major branches were
dehydrated and embedded in paraffin then sections 4 mm thick
were cut from paraffin blocks and deparaffinized in xylene,
rehydrated in a descending series of ethanol concentrations, and
prepared for histopathological and immunohistochemical studies.
3. Antibodies
Rabbit Anti-Human S100A4 polyclonal antibody (S100A4;
1:100; Zhongshan Golden Bridge), Mouse Anti-Human Actin
monoclonal antibody (a-SMA; Maixin Biotechnology), and Mouse
Anti-Human IgG monoclonal antibody (IgG; 1:3000; Santa Cruz)
were used as the primary antibodies in this study. As secondary
antibody, poly peroxidase-anti-mouse/rabbit IgG (Shanghai Long
Island) was used.
4. Immunohistochemistry
After being blocked with 3% H2O2, each section was incubated
overnight at 4uC with the desired primary antibodies, rinsed 3
times in phosphate buffered saline (PBS; pH 7.2) and incubated
with secondary antibody at 37uC for 30 minutes. After 3 more
rinses in phosphate buffered saline, the sections underwent color
development for 1 minute at room temperature in a substrate
medium containing 3,3-diaminobenzidine. After washed with
distilled water, the sections were counterstained with hematoxylin.
5. Statistical analysis
Statistical analysis involved use of SPSS 13.0 (SPSS Inc.,
Chicago, IL). A two-tailed P,0.05 was considered statistically
significant.
Results
1. Demographic data
We identified 65 patients with MMD in our institutions in
Chaoshan District. There were 29 men and 36 women. No
significant difference was observed in the gender distribution. The
ratio of female to male patients was 1.2. The mean age at
symptom onset was 41.7611.4 (range, 7–73) years (Table 1). The
mean onset age in male patients (42.4610.9) almost equaled to
female patients (41.2612.0). The primary symptoms included
headache (29/65), vomiting (28/65), and dizziness (21/65). 63
(97%) patients were adults over the age of 18, and only 2 (3%)
pediatric patients. Onset age distribution of the 65 patients was
found to have 1 peak at 40–49 year-old age group, and patients in
their thirties and forties accounted for the majority (72%). Female
patients followed the same pattern in age distribution, however,
male patients were frequently observed in their thirties. Positive
family history was observed in 4.6% of patients (3/65).
With comparison, high female-to-male ratios (about 2:1) were
found in United States and Japan but about a 1:1 ratio in China
Table 1. Summary of patients with MMD in Chaoshan
District.
a
No. of cases(%) Mean age Primary symptoms
Male 29(44.6) 42.4610.9 Headache 14/29; vomiting
10/29;
weakness in extremities 9/29;
dizziness 8/29; etc.
Female 36(55.4) 41.2612.0 Vomiting 18/36; headache
15/36;
dizziness 13/36; etc.
Total 65 41.7611.4 Headache 29/65; vomiting
28/65;
dizziness 21/65; etc.
aNo: number.
doi:10.1371/journal.pone.0036386.t001
Table 2. Comparison of MMD in different districts.
a
Districts No. of cases F/M
Age
distribution
Family
history
China [10,17] 1099
* 1.02 2 peaks 4.3%
Japan [5,9] 2416 1.84 2 peaks 10.8%
South Korea [15] 334 1.46 2 peaks 1.5%
United States [8,13–14] 154 2.35 2 peaks NA
Total 4089 1.53 2 peaks NA
aNo: number; F: female; M: male; NA: not available;
*including 65 MMD patients in our institutions.
doi:10.1371/journal.pone.0036386.t002
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Asian countries. Positive family history was frequently found in
patients from Asian countries.
2. Disease type
It is obvious that hemorrhage was much more common in
MMD patients (Figure 1). Intracranial hemorrhage affected 75%
(49/65) of patients with MMD. Cerebral ischemia occurred in
20% (13/65) of the patients. In the 49 hemorrhagic cases,
intracerebral hemorrhage (ICH) occurred in 30 cases (61%),
intraventricular hemorrhage (IVH) in 14 cases (29%), and
subarachnoid hemorrhage (SAH) in 5 cases (10%). Internal
carotid arteries and middle cerebral arteries were frequently
affected. Digital subtraction angiogram of a 32-year-old man
showing marked stenosis of the distal portion of the ICA (Figure 2).
3. Histopathology results for 3 cases
All 3 autopsy cases of MMD showed diffuse subarachnoid
hemorrhage on the brain surface. Fine vascular networks were
observed in the proximal of the bilateral middle cerebral arteries
and around the pons (Figure 3). Hemorrhage was found in
vascular networks but not aneurysms. The tonsils of the
cerebellum had no obvious impression.
Histopathology findings of intracranial vessels revealed a
narrowed lumen due to intimal fibrous thickening without
significant inflammatory cell infiltration, the vascular wall was
thickened. The internal elastic lamina was markedly tortuous and
stratified (Figure 4A & 4B). The internal elastic lamina of affected
arteries was tortuous, ruptured, straight or multilayered. Interest-
ingly, all 3 autopsy cases showed vacuolar degeneration in the
cerebrovascular smooth muscle cells (Figure 4C & 4D).
4. Immunohistochemistry results
The thickened intima of middle cerebral arteries were positive
for a-SMA (Figure 5A & 5D). S100A4 protein immunoreactivity
was strongly positive in the thickened intima and media (Figure 5B
& 5E). The expression of IgG was positive in intracranial vascular
smooth muscle cells, especially in the damaged internal elastic
lamina (Figure 5F). The Complement C3 immunoreactivity was
negative.
5. Follow-up
For the 62 cases of MMD from our institutions, the median
follow-up after the first diagnosis (n=40) was 24.8 months (range
Figure 1. Disease pattern of MMD in Chaoshan District.
doi:10.1371/journal.pone.0036386.g001
Figure 2. Digital subtraction angiogram (DSA)showing stenosis
of the distal portion of the ICA (white arrow).
doi:10.1371/journal.pone.0036386.g002
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PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e36386Figure 3. Macroscopical and microscopical findings at autopsy. A: malformation of the vascular network around the proximal middle
cerebral artery (white arrow); B: fine vascular network indicated by black arrows (Ponceau/Victoria blue staining,6100); C: subarachnoid hemorrhage
in the right parieto-temporal area; D: subarachnoid hemorrhage in right parietal lobe (H&E staining, 6100); yellow stars indicate the hemorrhagic
area.
doi:10.1371/journal.pone.0036386.g003
Figure 4. Photomicrographs of brain vessels in MMD patients. A and B: narrow lumen with intimal thickening and attenuation of media in
middle cerebral artery (Ponceau/Victoria blue staining, A: 640, B: 6100), black arrows indicate stratified internal elastic lamina, Figure 4B is an
enlarged region (box) of Figure 4A; C and D: vacuolar degeneration (black arrows) in cerebrovascular smooth muscle cells (H&E staining, C: 640, D:
6100), Figure 4D is an enlarged region (box) of Figure 4C.
doi:10.1371/journal.pone.0036386.g004
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collection. During the follow-up, 4 strokes occurred in 4 patients (3
hemorrhagic and 1 ischemic). All 4 strokes occurred during the
first 2 years after conservative treatment. The 2-year stroke-free
survival rate was 83%, with no changes in the 5-year survival rate
(Figure 6).
Discussion
This study showed no significant difference in the female-to-
male ratio (F/M=1.2) in MMD patients. Previous reports [5,8]
showed the female dominance in patients with MMD, in the
United States, the ratio of female to male was 2.5, and 1.8 in
Japan.
In the Japan series [5,9] there are 2 peaks in onset age
distribution. In our cases, however, there was only 1 peak in the
Figure 5. Immunohistochemical study of intracranial arteries. A and D: immunoreactivity indicating that a-SMA is detected in the thickened
intima of MCA of patients with MMD (black arrows), Figure 5D is an enlarged region (box) of Figure 5A; B and E: immunoreactivity indicating that
S100A4 protein is detected in the thickened intima and media smooth muscle cells (black arrows), Figure 5E is an enlarged region (box) of Figure 5B;
F: vascular smooth muscle cells, especially the damaged internal elastic lamina, showed intense immunoreactivity of IgG (black arrows); C: the same
area of Figure 5F, black arrows indicate the stratified internal elastic lamina (Ponceau/Victoria blue staining). The red stars indicate lumen of the blood
vessels. (A, B) 640, (C, D, E, F) 6200.
doi:10.1371/journal.pone.0036386.g005
Figure 6. Kaplan-Meier plot for stroke-free survival after treatment.
doi:10.1371/journal.pone.0036386.g006
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pediatric group in our institutions was not clear. An important
factor contributed to this phenomenon is that some pediatric
MMD patients were not diagnosed in time. Generally, pediatric
patients with MMD experienced ischemic symptoms, however,
because of their young age (less than 10 years old), they usually
could not expressed their symptoms clearly. In addition, the
parents’ educational background and socioeconomic status may
also have influence on their decisions to take the diagnostic tests or
not.
As mentioned above, intracranial hemorrhage as clinical
manifestations were much more common than ischemia in our
65 cases. Because 97% patients were adults, our result supported
that most adult MMD patients experienced intracranial hemor-
rhage. The 2-year stroke-free survival rate was 83%, with no
changes in the 5-year survival rate, so the critical period is 2-year-
period after the first onset.
Since MMD was initially described in Japan, it has been
reported frequently, especially in East Asia. In China, MMD has
been described frequently in the literature. Recently, a study of the
clinical features of MMD in China was published [10]; however,
the number of cases in a single institution are too few for in-depth
study; many cases that occur in mainland China may be neglected
or reported by case reports. To make comparisons among different
districts, we searched the literature [5,8–17] to comprehensively
compare cases of MMD worldwide.
Previous study [18] showed a female dominance in patients with
MMD. We found about a 2:1 ratio for the United States and
Japan but about a 1:1 ratio in China (Table 2). The positive family
history was frequently found in patients from Asian countries. The
age distribution was bimodal in all areas, including Asian
countries. The onset age was predominantly 0–9 years and 30–
39 years (Figure 7).
Histopathological changes of the distal portion of the internal
carotid arteries and the beginning of the middle cerebral arteries
are fibrocellular thickening of the intima and markedly wavy, often
ruptured or duplicated elastic lamina. These findings of intracra-
nial vessels are consistent with previous reports [7,19–23]. The
changes in intracranial vessels may increase the fragility of vessels,
which are susceptible to bleeding when blood pressure fluctuates.
Immunohistochemical examination showed a-SMA-positive
cells in the thickened intima, which suggested that vascular
smooth muscle cells migrated into the intima and proliferated.
Strikingly, S100A4 protein and IgG immunoreactivity were
strongly positive in the media and intima of the major arteries
in MMD patients.
The deposits of IgG in vascular wall may underlie the disruption
of internal elastic lamina, facilitating S100A4-positive SMCs
migrate into intima. S100A4 protein belongs to the S100 family
of calcium binding proteins. The role of S100A4 in tumor
progression and metastasis is well documented [24,25]. Recently,
implications of S100A4 protein in various non-malignant
pathological conditions have been demonstrated [26]. Tight
association between S100A4 expression and smooth muscle cells
phenotypic modulation in porcine and human coronary arteries
was also demonstrated. The aberrant expression of S100A4
protein is associated with upregulation SMCs proliferative and
migratory activities [27]. So, we speculate that MMD might be
caused by immune-related factors and then internal elastic lamina
disrupted, smooth muscle cells in the media changed morpholog-
ically and functionally, by, for example, vacuolar degeneration in
the smooth muscle cells and migrated into intima, resulting in
lumen stenosis or occlusion.
In conclusion, we performed a retrospective analysis of patients
with MMD, and described the clinical features and outcomes.
Histopathological and immunohistochemical findings of intracra-
nial vessels from 3 autopsy cases suggested that immune-related
factors may involved in the functional and morphological changes
of smooth muscle cells, which finally caused the thickened intima.
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